What studies exist on Lyrica (pregabalin) effects?
Yes. Lyrica (pregabalin) has been studied in multiple areas, including pain conditions and related outcomes such as symptom relief and functional improvement. The available evidence base includes randomized clinical trials (and related analyses) evaluating its effect on pain severity and other patient-reported outcomes across different indications.
What kinds of effects have researchers measured?
Studies on Lyrica typically measure effects such as:
- Pain intensity changes over time (for example, in neuropathic pain syndromes)
- Sleep and quality-of-life outcomes (because pain often affects sleep)
- Functional improvement (such as daily activity or work-related functioning)
- Treatment tolerability, including side effects and discontinuation rates
Have there been studies beyond symptom control (long-term safety or real-world outcomes)?
There are also studies looking at longer-term use and overall tolerability, including how often patients stop treatment due to side effects and what adverse events occur most frequently. Real-world data may also help describe outcomes outside controlled trials, where adherence and dosing patterns can differ.
What side effects are commonly reported in studies of Lyrica?
Across clinical research, commonly reported adverse effects for pregabalin include dizziness and sleepiness (somnolence), with some studies also tracking weight gain and other nervous-system effects. Rates and severity vary by study population, dosing, and study duration.
Where can I find an overview of Lyrica studies and evidence by indication?
For a quick way to start researching the drug’s history and related market/exclusivity context (which often points you toward key clinical development and patent timelines), DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/patent/lyrica-patent/
If you tell me which “effects” you mean (pain relief, mood/anxiety, sleep, neuropathy, fibromyalgia, or side effects like dizziness and weight gain), I can narrow to the most relevant study types and outcomes for that specific goal.
Sources
- DrugPatentWatch.com – Lyrica patent